Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research

Gianfranco De Feo; Luciano Frontini; Silvia Rota; Antonio Pepe; Simona Signoriello; Roberto Labianca; Alberto Sobrero; Sabino De Placido; Francesco Perrone

doi:10.1136/medethics-2012-100803

Article menu

Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts

PDF

Clinical ethics

Paper

Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research

Share this article

Click the icon of the social media platform on which you would like to share this article.

Share This Article:

Email this article to a friend

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

Your email: *

Your name: *

Send to: *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research

Message subject: (Your Name) has forwarded a page to you from Journal of Medical Ethics

Message body: (Your Name) thought you would like to see this page from the Journal of Medical Ethics web site.

Your personal message:

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Read the full text or download the PDF:

Log in using your username and password

For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?

Forgot your user name or password?

Other content recommended for you

Impact of recent legislative bills regarding clinical research on Italian ethics committee activity
L Porcu et al., Journal of Medical Ethics, 2008
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients
Anton Oseledchyk et al., International Journal of Gynecologic Cancer, 2020
Young adults' opinions of Philip Morris and its television advertising
L Henriksen et al., Tobacco Control, 2002
Multicentre trials review process by research ethics committees in Spain: where do they stand before implementing the new European regulation?
R Dal-Ré et al., Journal of Medical Ethics, 2005
Research ethics committee decision-making in relation to an efficient neonatal trial
C Gale et al., Archives of Disease in Childhood - Fetal and Neonatal Edition, 2017
SYMptom monitoring with Patient-Reported Outcomes using a web application among patients with Lung cancer in the Netherlands (SYMPRO-Lung): study protocol for a stepped-wedge randomised controlled trial
Nicole E Billingy et al., BMJ Open, 2021
Factors that influence attitude and enforcement of the smoke-free law in Turkey: a survey of hospitality venue owners and employees
Angela Aherrera et al., Tobacco Control, 2017
What do research ethics committees say about applications to conduct research involving children?
E Angell et al., Archives of Disease in Childhood, 2010
Research ethics committees in Europe: implementing the directive, respecting diversity
A Hedgecoe et al., Journal of Medical Ethics, 2006
Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen
Cameron E Snell et al., Journal of Clinical Pathology, 2017

Log in using your username and password

Main menu

Log in using your username and password

You are here

Share this article

Email this article to a friend

Request permissions

Read the full text or download the PDF:

Log in using your username and password

Other content recommended for you